SBK Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-19
Closed -$8.48K – 426
2026
Q1
$8.48K Buy
+19
New +$8.86K 0.01% 170

Other funds holding VRTX

SBK Financial's VRTX Position: Q2 2026 in Review

SBK Financial sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 19 shares — an estimated $8.48K sold.

SBK Financial first reported a position in VRTX in Q1 2026 and held it in 1 quarter. The position peaked at $8.48K in Q1 2026. 1,772 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • SBK Financial reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • SBK Financial sold 19 Vertex Pharmaceuticals shares in Q2 2026, an estimated $8.48K.
  • SBK Financial first reported a position in Vertex Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • SBK Financial's Vertex Pharmaceuticals position peaked at $8.48K in Q1 2026.
  • 1,772 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on SBK Financial's 13F filing for Q2 2026, filed 2 Nov 2026.